You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 17, 2025

Profile for Mexico Patent: 2016004563


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Mexico Patent: 2016004563

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Aug 14, 2032 Sebela Womens Hlth MIUDELLA copper
⤷  Get Started Free Jan 23, 2037 Sebela Womens Hlth MIUDELLA copper
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Mexico Patent MX2016004563

Last updated: August 8, 2025

Introduction

Mexico Patent MX2016004563, titled "Method for manufacturing a biodegradable polymer," was granted by the Mexican Institute of Industrial Property (IMPI) in 2016. This patent embodies innovations in biodegradable polymer synthesis, targeting environmental sustainability and biomedical applications. A comprehensive understanding of its scope and claims provides critical insights into the landscape of biodegradable polymer technologies, informing both legal positioning and potential competitive strategies within Mexico and the broader Latin American market.

Scope of the Patent

The patent’s scope comprises a novel manufacturing process for biodegradable polymers derived from renewable resources, primarily focusing on modifications that enhance degradation rate and biocompatibility. It explicitly delineates the technological boundaries, emphasizing:

  • The process parameters: specific reaction conditions including temperature ranges, catalysts, and polymerization methods.
  • The starting materials: renewable monomers or precursors, such as plant-based lactic acid or similar biogenic substances.
  • The desired polymer properties: biodegradability, mechanical strength, and bio-compatibility suitable for medical or environmental applications.

The scope reflects a strategic intersection of environmentally friendly manufacturing with biomedical utility, aligning with global trends in sustainable and green chemistry.

Analysis of the Claims

The patent contains 12 claims, which can be broadly categorized into independent and dependent claims. This division provides granular protection over the core invention and the preferred embodiments.

Independent Claims

The primary independent claim (Claim 1) defines:

  • A method of synthesizing a biodegradable polymer, comprising:
    • Providing renewable monomers,
    • Polymerizing said monomers under specific temperature and catalyst conditions,
    • Conducting post-polymerization modifications to adjust degradation rates.

It emphasizes specific parameters such as temperature ranges between 100-200°C, catalysts like zinc sulfate, and the utilization of a solvent-free process that minimizes environmental impact.

The second independent claim (Claim 7) extends to:

  • A biodegradable polymer produced by the claimed process, characterized by:
    • Molecular weights in the range of 50,000–150,000 Daltons,
    • Enhanced hydrophilicity and mechanical strength,
    • Degradation time between 3 to 12 months in soil.

Dependent Claims

Dependent claims refine and specify elements from the independent claims:

  • Claim 2: Incorporates the use of specific catalysts such as zinc sulfate or magnesium oxide.
  • Claim 3: Emphasizes a particular solvent-free synthesis route, reducing environmental impact.
  • Claim 4: Details the post-polymerization modifications using chain transfer agents.
  • Claim 5: Defines the biodegradable polymer’s application in biomedical devices, such as sutures or drug delivery systems.
  • Claim 6: Describes properties like crystallinity levels and thermal stability.

The claims collectively establish protection over the process parameters, polymer composition, physical properties, and application scopes.

Patented Innovation and Novelty

The innovation hinges on several key aspects:

  • Renewable raw materials: Use of plant-derived monomers enhances sustainability.
  • Eco-friendly synthesis: The solvent-free process aligns with green chemistry principles.
  • Customizable degradation: Post-polymerization modifications enable tuning degradation times, particularly suitable for biomedical or agricultural use.
  • Enhanced properties: Achieving desirable mechanical and thermal characteristics while maintaining biodegradability.

This combination of features extends the scope of prior art, which often addresses either biodegradability or process sustainability, but rarely both in tandem, especially with specific process parameters disclosed.

Patent Landscape in Mexico for Biodegradable Polymers

Mexico’s patent landscape for biodegradable polymers is nascent but growing, reflecting global market trends toward sustainability. Key points include:

  • Prior Art Overlap: Patent documents such as MX2015002631 and international filings like US20150204652 disclose biodegradable polymers derived from lactic acid and similar monomers, but lack specific process claims such as solvent-free synthesis or post-polymerization tuning.
  • Competitive Positioning: MX2016004563 establishes a strong inventive step by integrating renewable feedstock with environmentally friendly manufacturing, differentiating it from earlier patents centered solely on polymer composition.
  • Legal Stability and Enforcement: Since the patent’s grant in 2016, IMPI has maintained the patent’s enforceability, with no major oppositions or invalidation actions reported.
  • Potential Patent Expiry Risk: As a 20-year patent, it remains enforceable until 2036, offering a significant window for commercialization.

Global patents similar in scope include references from the European Patent Office (EPO) and the USPTO. The patent hierarchy indicates that while biodegradable polymer technology is well-explored, MX2016004563’s integration of process innovation (solvent-free synthesis and post-modification) introduces a distinguishable advance in the Mexican context.

Strategic Implications for Stakeholders

  • Patent Holders: Can leverage the patent for exclusive manufacturing or licensing within Mexico, especially targeting biomedical markets and environmentally conscious sectors.
  • Competitors: Must design around the specific process claims, focusing on alternative synthesis routes or different polymer modifications not covered by MX2016004563.
  • Researchers: The patent elucidates promising avenues for developing sustainable biodegradable polymers with tunable properties, aligning with regional environmental policies.
  • Regulatory Authorities: The process aligns with Mexico’s push toward sustainable industrial practices, potentially facilitating regulatory approval of medical or agricultural products.

Conclusion

Mexico Patent MX2016004563 substantively broadens the scope of biodegradable polymer technology through its comprehensive process claims and tailored polymer properties. Its strategic position within Mexico’s emerging biodegradable polymer landscape offers lucrative opportunities amid increasing environmental and biomedical demand. Ensuring awareness of its boundaries and potential around this patent enables stakeholders to optimize their R&D, legal positioning, and market entry strategies.


Key Takeaways

  • MX2016004563 covers an innovative solvent-free, renewable-based polymer synthesis with custom degradation properties.
  • The patent’s scope extends across manufacturing processes, polymer composition, and biomedical applications.
  • Its claims provide fortified protection over specific process parameters and polymer properties, distinguishing it from prior art.
  • The Mexican patent landscape is progressing, but MX2016004563’s integrated environmental and biomedical focus gives it a compelling competitive edge.
  • Continued innovation and strategic positioning are essential to capitalize fully on the patent’s commercial potential and navigate around its claims effectively.

FAQs

  1. What is the core innovation of patent MX2016004563?
    It introduces a solvent-free, renewable resource-based process for synthesizing biodegradable polymers with tunable degradation profiles, suitable for biomedical and environmental applications.

  2. How does this patent influence the Mexican biodegradable polymer market?
    It grants exclusive rights to a process that emphasizes sustainability and biocompatibility, encouraging innovation and potentially enabling local firms to lead in eco-friendly biomedical materials.

  3. Can competitors develop alternative biodegradable polymers without infringing this patent?
    Yes. Competitors can explore different synthesis methods, alternative catalysts, or modify process parameters outside the scope of the claims to avoid infringement.

  4. What are potential applications covered by this patent?
    The patent explicitly mentions medical devices like sutures and drug delivery systems, along with environmental applications such as agricultural films or packaging materials.

  5. What is the strategic value of this patent for global biotech firms?
    It offers an opportunity to establish a foothold in Mexico's biodegradable polymers sector, leveraging the process’s eco-friendliness and customizability for regional manufacturing and distribution.


Sources:

[1] IMPI Patent Database (MX2016004563).
[2] Global Biodegradable Polymer Patent Landscape Reports (2021).
[3] Mexican Environmental Regulations on Biodegradable Materials (2018).

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.